PharmaPodia 07 22 2010 Quick Bits!

Hello!


Quick Bits or Update on the Way!


^_^


enjoy your weekend!


Pharmapodia

******

• Preliminary results of the phase II study using tenofovir as the HIV prevention in pay or bisexual patients showed safety. The study was conducted through the collaboration between different government, state, and public agencies. (http://www.thebody.com/content/news/art57741.html)

• Merck & Co has announced that it will purchase the dengue fever vaccine research unit of Hawaii Biotech. Hawaii Biotech has just filed Chapter 11 bankruptcy in December. Its tetravalent dengue vaccine is currently in the phase I trial. Other vaccine such as West Nile virus, has just completed phase 1 trial. (http://vaccinenewsdaily.com/news/214275-merck-buys-dengue-fever-vaccine-research-unit)

• The US FDA has approved the new dose of Aricept or donezepil as the treatment of moderate-to-severe Alzheimer’s Disease, Eisaie and Pfizer announced. (http://online.wsj.com/article/BT-CO-20100723-714235.html)

• The development of tanespimycin as the potential treatment of multiple myeloma has been halted. Bristol-Myers Squibb decided to terminate the development of the program due to difficult manufacturing and its short-remaining patent life. Tanespimycin is a heat sock protein 90 inhibitor. (http://www.myelomabeacon.com/news/2010/07/22/tanespimycin-development-halte/)

PharmaPodia 07 21 2010

Good Thursday!


I'm currently @ the airport...quick post for the day.  I might or might not get to the podcast. It all depends on to how tired I am when I get home tonight.


In a mean time, enjoy!

• NVC-422 showed efficacy in proof-of-concept study
• Initiation for the phase II trial of hGH-CTP
• Phase III clinical trial using carfilzomib, low dose methasone, and lenalidomide has been initiated
• Combination therapy of bevacizumab and standard chemotherapy showed less adverse vents in non-small cell lung cancer

Pharmapodia 07 21 2010

Welcome!

Are you ready for the weekend?  Summer's end is approaching so fast....it will be here before I even know it.  In any case, let's just enjoy the podcast for today.

Here are several highlights:

•  New study of rotavirus vaccine will be conducted
• ASG-ME5's phase I trial has been initiated as the treatment of pancreatic cancer
• Caprisa004 gel showed effectiveness in prevention of HIV transmission
• ARC-4558 showed significant pain reduction in diabetic neuropathy patients
• The generic version of Phentermine has been approved
• The following companies have released its financial results: Biogen Idec, Gilead, nSpire Health, Boston Scientific
• Partnerships have been formed between: Target Health & LifeOnKey, Medical Device Consultants & Clinical Development - Support Services.
• Kika gets investment from BioStata
• Acorda gets funds from NIH
• SimpleCTMS has been launched as a web-based clinical trial management

Don't forget to come and see you next time,

Pharmapodia

PharmaPodia Podcast 07 20 2010

Hello and Welcome!

The new podcast is up!


Several of the highlights:

• NanoViricides presented results of its anti-Ebola Agents at the ASV
• MDMA and psychotherapy combination showed efficacy in chronic PTSD patients
• Survival data of phase I of AEG35156 has been released.
• FDA has apporve Lorus' plan to initiate phase 1 trial of LOR-253
• Hemispherx BioPharma has been allowed to initiate the trial of Alferon N Injection in India.
• Phase II trial of Imetelstat has begun.
• Phase II trial of bafetinib has enrolled its first patient.
• Ziopharm initiates phase III study of plaifosfamide as treatment of metastatic soft tissue sarcoma
• Catapres-TTS patches produced by Mylan has been approved by the FDA
• Banzel has been accepted for review by the FDA
• The new generationn Actonel delayed release tablet's new PDUFA is October 24, 2010.
• Encorium acquires Progenitor holdings

PharmaPodia Podcast 07 19 2010

Hello!

Podcast is back! Hope everyone has a great weekend!


Monday's Podcast is relatively short!  So enjoy and don't forget to come back to visit us!

See you then,

Pharmapodia!

****************

Hello!


This is the late report that should have come out yesterday.  The place I was at did not allow connection to blogspot.  But anyway, we're now back online.